Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2023-10-10 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PHN - Avvio programma azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is an official communication from PHARMANUTRA S.P.A. dated October 10, 2023, titled 'PHN - Avvio programma azioni proprie' (PHN - Start of own share purchase program). The text explicitly details the initiation of a share buyback program, including the maximum number of shares, maximum consideration (Euro 1,100,000), operational limits, and the intermediary involved (Intermonte SIM S.p.A.). This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing type code is POS.
2023-10-10 Italian
PR - FIRST SALES ON THE US MARKET
Regulatory Filings Classification · 1% confidence The document is titled 'PR - FIRST SALES ON THE US MARKET' and is identified as 'Informazione Regolamentata' (Regulated Information) from Euronext Star Milan, dated October 3, 2023. It announces the start of operations and the first sales of the US subsidiary. This type of announcement, which communicates a specific business event (market entry/first sales) via a press release format, fits best under the general category of Regulatory Filings (RNS) or potentially an Earnings Release (ER) if it contained core financial metrics, but since it's a specific operational update rather than a periodic financial summary, RNS is more appropriate as a general regulatory announcement. However, given the content is a press release announcing a significant operational milestone (launching sales in a new major market), and it is not a standard periodic report (10-K, IR, ER), it falls under the category of general regulatory announcements. Since 'RNS' is the fallback for miscellaneous regulatory filings, and this is a formal communication to the market about a business development, RNS is the most suitable classification among the provided options, as it is not a specific report type like 10-K or IR, nor is it a management discussion (MDA) or an earnings release (ER). It is a general regulatory disclosure.
2023-10-03 English
CS - PRIME VENDITE SUL MERCATO AMERICANO
Regulatory Filings Classification · 1% confidence The document is titled 'CS - PRIME VENDITE SUL MERCATO AMERICANO' (CS - First Sales on the American Market) and details the operational setup and commencement of sales for the US subsidiary of PharmaNutra S.p.A. It discusses the structure, personnel, product lines being commercialized, and the launch of the e-commerce site. This type of announcement, detailing significant business updates, operational milestones, and commercial strategy, is characteristic of a general business communication or press release. Since it is not a formal financial report (like 10-K or IR), a specific earnings release (ER), or a management discussion (MDA), and it is a direct announcement of a business event, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for official company announcements that don't fit elsewhere, especially given the Italian 'Informazione Regolamentata' header (REGEM). It is not a short announcement pointing to a separate report, as it contains substantial detail about the operational launch itself.
2023-10-03 Italian
INTERIM MANAGEMENT REPORT AS AT 30 JUNE 2023
Interim / Quarterly Report Classification · 1% confidence The document is a 'First half financial report' for PharmaNutra S.p.A. covering the period ending 30 June 2023. It contains comprehensive financial statements, including the consolidated balance sheet, income statement, cash flow statement, and explanatory notes, as well as a management report on operations. It is clearly an interim financial report rather than an annual report or a simple announcement, as it provides detailed financial data and analysis for the six-month period. H1 2023
2023-09-19 English
RELAZIONE FINANZIARIA SEMESTRALE AL 30 GIUGNO 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RESOCONTO INTERMEDIO DI GESTIONE RELAZIONE FINANZIARIA SEMESTRALE' (Interim Management Report - Half-Year Financial Report) for the period ending June 30, 2023. It contains comprehensive financial statements (Consolidated Balance Sheet, Income Statement, Cash Flow Statement), notes to the financial statements, and management's discussion and analysis. It is a formal, substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2023
2023-09-19 Italian
Half-Year Financial Report as of 30 June 2023
Report Publication Announcement Classification · 1% confidence The document text explicitly states the subject as "Half-Year Financial Report as of 30 June 2023" and mentions that this report, along with the Auditors' Report, is now available at the registered office, on the website, and on the authorized storage mechanism. The document itself is very short (4379 characters) and serves primarily to announce the publication of the full report, rather than containing the comprehensive financial statements of the report itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), as per the 'MENU VS MEAL' rule. If the document contained the full financial tables, it would be classified as an Interim/Quarterly Report (IR).
2023-09-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.